Posts

Alopecia Treatment

Alopecia Treatment

Global Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2028

Alopecia treatment (hair loss) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the alopecia treatment (hair loss) market to account to USD 5,461.35 million by 2028 growing at a CAGR of 6.0% in the above-mentioned forecast period. Rising prevalence of alopecia (hair loss) globally and extensive research & development activity in alopecia treatment (hair loss) has been directly impacting the growth of alopecia treatment (hair loss) market.

Alopecia is a condition that causes hair to fall out in small patches, which can be unnoticeable. These patches may connect, however, and then become noticeable. The condition develops when the immune system attacks the hair follicles, resulting in hair loss.

Increasing need for effective treatment for alopecia (hair loss) is the main driving factor for the alopecia treatment (hair loss) market. Rising pharmaceutical industries and various research & clinical studies is driving the alopecia treatment (hair loss) market. Various innovative clinical programmes is an opportunity for the alopecia treatment (hair loss) market.

Lack of awareness in rural countries is a big challenge for the alopecia treatment (hair loss) market. However, high cost of treatment is the main restraint in the growth of alopecia treatment (hair loss) market during the forecast period of 2021-2028.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.

In March 2018, Johnson & Johnson Services, Inc. teamed up with JW Pharmaceutical to improve the sales of its product which is Rogaine, a hair loss treatment including minoxidil. JW Pharmaceutical has signed a distributorship agreement with J&J in November 2017. Rogaine is FDA approved hair loss treatment and is considered a top-selling hair loss treatment. This lead enabled the company to gain more product sales which have increased the company’s overall revenue.

Alopecia Treatment (Hair Loss) Market Scope and Market Size

Alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, gender, form, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on disease type, the alopecia treatment (hair loss) market is segmented into non‒cicatricial alopecia, cicatricial alopecia, traction alopecia and others.
  • Based on treatment, the alopecia treatment (hair loss) market is segmented into localized therapies, systemic therapies, medical devices and herbal treatment.
  • Based on gender, the alopecia treatment (hair loss) market is segmented into male and female.
  • Based on form, the alopecia treatment (hair loss) market is segmented into oral, topical and parenteral.
  • Based on end user, the alopecia treatment (hair loss) market is segmented into hospitals, home healthcare and dermatology centers.
  • Based distribution channel, the alopecia treatment (hair loss) market is segmented into direct tender, retail sales and pharmacies.

Alopecia Treatment (Hair Loss) Market Country Level Analysis

Alopecia treatment (hair loss) market is segmented into is analysed and market size insights and trends are provided by country, disease type, treatment, gender, form, end user and distribution channel as referenced above.

The countries covered in the alopecia treatment (hair loss) market is segmented into report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the alopecia treatment (hair loss) market. The regional market has been driven by common form of alopecia and people with alopecia aerate affects. However, growing market with new players is the main factor propelling the growth of the regional market. The market in Asia-Pacific is expected to exhibit a substantial growth rate during the forecast period 2021-2028 due to rise in prevalence of alopecia and rising usage of hair care therapies for the treatment.

The country section of the alopecia treatment (hair loss) market is segmented into report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Alopecia treatment (hair loss) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for alopecia treatment (hair loss) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the alopecia treatment (hair loss) market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Alopecia Treatment (Hair Loss) Market Share Analysis

Alopecia treatment (hair loss) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to alopecia treatment (hair loss) market.

The major players covered in the alopecia treatment (hair loss) market report are Alès Groupe, Gerolymatos International SA, iGrow Laser, Lexington Intl., LLC., Curallux, LLC., Follicum AB, HCell Inc., Freedom Laser Therapy, Inc., Taisho Pharmaceutical Holdings Co., Ltd., Vita-Cos-Med Klett-Loch GmbH, Vitabiotics Ltd., WOCKHARDT, Teva Pharmaceuticals USA, Inc., Pfizer Inc., Par Pharmaceutical, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., Abbott, Zydus Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Cipla Inc., Sun Pharmaceutical Industries Ltd., Merck Sharp & Dohme Corp., Aurobindo Pharma, Perrigo Company plc, Viviscal Limited, Dr. Kurt Wolff GmbH & Co. KG, Nanogen, Labo International S.r.l., Watermans, WON TECH Co., Ltd., PureTech are among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Global Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2028

Source

Recent Posts

Alopecia Treatment

Alopecia Treatment

Global Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2028

Alopecia treatment (hair loss) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the alopecia treatment (hair loss) market to account to USD 5,461.35 million by 2028 growing at a CAGR of 6.0% in the above-mentioned forecast period. Rising prevalence of alopecia (hair loss) globally and extensive research & development activity in alopecia treatment (hair loss) has been directly impacting the growth of alopecia treatment (hair loss) market.

Alopecia is a condition that causes hair to fall out in small patches, which can be unnoticeable. These patches may connect, however, and then become noticeable. The condition develops when the immune system attacks the hair follicles, resulting in hair loss.

Increasing need for effective treatment for alopecia (hair loss) is the main driving factor for the alopecia treatment (hair loss) market. Rising pharmaceutical industries and various research & clinical studies is driving the alopecia treatment (hair loss) market. Various innovative clinical programmes is an opportunity for the alopecia treatment (hair loss) market.

Lack of awareness in rural countries is a big challenge for the alopecia treatment (hair loss) market. However, high cost of treatment is the main restraint in the growth of alopecia treatment (hair loss) market during the forecast period of 2021-2028.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.

In March 2018, Johnson & Johnson Services, Inc. teamed up with JW Pharmaceutical to improve the sales of its product which is Rogaine, a hair loss treatment including minoxidil. JW Pharmaceutical has signed a distributorship agreement with J&J in November 2017. Rogaine is FDA approved hair loss treatment and is considered a top-selling hair loss treatment. This lead enabled the company to gain more product sales which have increased the company’s overall revenue.

Alopecia Treatment (Hair Loss) Market Scope and Market Size

Alopecia treatment (hair loss) market is segmented on the basis of disease type, treatment, gender, form, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on disease type, the alopecia treatment (hair loss) market is segmented into non‒cicatricial alopecia, cicatricial alopecia, traction alopecia and others.
  • Based on treatment, the alopecia treatment (hair loss) market is segmented into localized therapies, systemic therapies, medical devices and herbal treatment.
  • Based on gender, the alopecia treatment (hair loss) market is segmented into male and female.
  • Based on form, the alopecia treatment (hair loss) market is segmented into oral, topical and parenteral.
  • Based on end user, the alopecia treatment (hair loss) market is segmented into hospitals, home healthcare and dermatology centers.
  • Based distribution channel, the alopecia treatment (hair loss) market is segmented into direct tender, retail sales and pharmacies.

Alopecia Treatment (Hair Loss) Market Country Level Analysis

Alopecia treatment (hair loss) market is segmented into is analysed and market size insights and trends are provided by country, disease type, treatment, gender, form, end user and distribution channel as referenced above.

The countries covered in the alopecia treatment (hair loss) market is segmented into report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the alopecia treatment (hair loss) market. The regional market has been driven by common form of alopecia and people with alopecia aerate affects. However, growing market with new players is the main factor propelling the growth of the regional market. The market in Asia-Pacific is expected to exhibit a substantial growth rate during the forecast period 2021-2028 due to rise in prevalence of alopecia and rising usage of hair care therapies for the treatment.

The country section of the alopecia treatment (hair loss) market is segmented into report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Alopecia treatment (hair loss) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for alopecia treatment (hair loss) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the alopecia treatment (hair loss) market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Alopecia Treatment (Hair Loss) Market Share Analysis

Alopecia treatment (hair loss) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to alopecia treatment (hair loss) market.

The major players covered in the alopecia treatment (hair loss) market report are Alès Groupe, Gerolymatos International SA, iGrow Laser, Lexington Intl., LLC., Curallux, LLC., Follicum AB, HCell Inc., Freedom Laser Therapy, Inc., Taisho Pharmaceutical Holdings Co., Ltd., Vita-Cos-Med Klett-Loch GmbH, Vitabiotics Ltd., WOCKHARDT, Teva Pharmaceuticals USA, Inc., Pfizer Inc., Par Pharmaceutical, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., Abbott, Zydus Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Cipla Inc., Sun Pharmaceutical Industries Ltd., Merck Sharp & Dohme Corp., Aurobindo Pharma, Perrigo Company plc, Viviscal Limited, Dr. Kurt Wolff GmbH & Co. KG, Nanogen, Labo International S.r.l., Watermans, WON TECH Co., Ltd., PureTech are among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Global Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2028

Source

Recent Posts

Alopecia Treatment Market Trends

Alopecia Treatment Market Trends

Alopecia Treatment Market Trends, Demand, Growth, Opportunities and Key Manufacturers Forecast to 2023

Industry Outlook and Trend Analysis

The Alopecia Treatment Market has encountered significant development in the recent years and is anticipated to grow tremendously over the forecast period.

Alopecia also recognized as hair-loss or baldness is a medicinal condition that alludes to the loss of hairs from the head or any part of the body. The condition can happen in both male and female and at any age.

There are five main kind of alopecia to be specific; androgenic alopecia, ciatricial alopecia, androgenic alopecia, alopecia totalis, and traction alopecia.

Alopecia areata is a typical autoimmune disorder in which the safe arrangement of body assaults the sound hair follicle prompting hair fall.

Development of the alopecia treatment market is fundamentally determined by expanding interest in hair loss treatment drugs with improved viability and insignificant reactions.

For instance, as of late cytokine therapy too regenerative cell treatment is picking up demand for treatment of different sorts of alopecia. Treatment with cytokine treatment has expanded capacity in hair regrowth bringing about hair follicle cells to get differenced and multiplied while controlling hair growth cycle.

Disease Type Outlook and Trend Analysis

Increasing pervasiveness of alopecia areata has been developing essentially over the years credited to expanding predominance of different dermatology related skin issue. On the basis of value, alopecia areata fragment is evaluated to represent a major share of the market over the forecast period. The fragment is anticipated to pick up traction owing to increasing awareness over the forecast period.

Request for Free Sample@ www.qurateresearch.com/report/sample/CnM/QBI-CMR-CnM-54037

Treatment Type Outlook and Trend Analysis

Topical medications incorporate lotions, gels, creams, foam, and shampoos, while the injectable treatment composes section incorporates steroids, platelet-rich plasma therapy, and injectable fillers. Propecia, an oral drug is at present the main FDA affirmed medication in the treatment of alopecia. Restricted clinical efficacy exhibited by such medicines would hamper market and income development of established products over the figure time frame.

End User Outlook and Trend Analysis

Dermatology and trichology clinics section is the most elevated income supporter of the alopecia treatment market trailed by home care settings and end-user portions. Over the counter distribution and rising level of e-Commerce, implementation is anticipated to prompt expanded selection of topical hair loss treatments in home care settings.

Regional Outlook and Trend Analysis

North America, trailed by Europe, is foreseen to overwhelm the alopecia treatment market all through the conjecture time frame. Asia Pacific is anticipated to witness the speediest development attributable to the upheaval of the middle-aged populace in the area. Likewise, the district is observing sound development as far as GDP, which is anticipated to move development at solid digits. The Middle East and Africa and Latin America are foreseen to encounter sluggish development amid the conjecture time frame.

Competitive Insights

The leading players in the market are Ranbaxy Laboratories, Dr. Reddy’s Laboratories, Nanogen, Merck & Co, Vitabiotics, Viviscal, Kirkland Signature, Cipla, Phyto – Alès Groupe and Johnson and Johnson. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Alopecia Treatment Market is segmented based on regions as follows-

By Region

North America
U.S.
Canada
Mexico

Europe
Germany
UK
France
Russia
Italy

Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America
Brazil
Argentina
Columbia
Rest of South America

Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA

Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

About Us:

Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Alopecia Treatment Market Trends

Source

Hair Loss and Balding in Women

Nolopecia Balding and Prostate Cancer

Balding and Prostate Cancer: Lilac Corp reviews a study and recommends Nolopecia, a natural treatment for hair loss

All natural hair loss supplement sold by Lilac Corp

Lilac Corp reviews a study that tested a possible link between early hair loss and prostate cancer.

Nolopecia, targets the latent viruses in the body. This helps the body maintain a normal level of the 5alpha-R, DHT, and AR proteins. A normal level of these proteins stimulates hair growth.”

A study showed that men with very early onset balding are more likely to develop aggressive prostate cancer, and at a younger age [1]. Some prostate cancers are more dangerous than others. Prostate cancer and androgenic alopecia, also called male pattern baldness, are both dependent on androgen hormones.

The study surveyed 1,941 men and found that men balding at age 20 years had a 50% higher chance of developing aggressive prostate cancer.

Also, these men were diagnosed with cancer an average of 16 months earlier than non-balding men.

Men balding at age 40 years and older, or non-balding men did not have the increased risk. Research like this is important because it helps to identify groups of men with a higher risk for aggressive cancer.

Men who are at a higher risk can perform regular screening tests for prostate cancer and should be followed up closely with their doctor.

For men (and women), who suffer from hair loss and balding, Lilac Corp recommends the natural treatment Nolopecia. Lilac Corp is the company that invented the highly effective and unique antiviral natural treatments Gene-Eden-VIR and Novirin.

The new treatment, called Nolopecia, targets the latent viruses in the body. This helps the body maintain a normal level of the 5alpha-R, DHT, and AR proteins. A normal level of these proteins stimulates hair growth.

There are many treatments for hair loss on the market.

However, only Nolopecia targets the latent viruses that cause the increase in 5alpha-R, DHT, and AR observed in people with hair loss and balding.

About Lilac Corp:

Lilac Corp specializes in the development of biology-based patent protected natural treatments. Currently, Lilac Corp is selling four products: Gene-Eden-VIR, Novirin, Nolopecia, and Noacnin. Lilac Corp ships its products to more than 100 countries around the world.

What makes Lilac Corp special is that all its products are tested in clinical studies that follow FDA guidelines. To ensure transparency, the results of the clinical studies are published in leading scientific journals. Lilac Corp also offers a 90-day money back guarantee.

Source:
[1] Papa, N., MacInnis, R., English, D., Bolton, D., Davis, I., & Lawrentschuk, N. et al. (2017). Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study. Cancer Causes & Control, 29(1), 93-102. doi: 10.1007/s10552-017-0981-0

Source

Improved Minoxidil Formulation Safe, Effective for Androgenetic Alopecia

alopecia market

Alopecia Market: Global Investment Analysis

Alopecia Market: Global Investment Analysis, Size, Challenges, Opportunities and Forecast by 2022

According to the Global Alopecia Market report, the Alopecia Market accounted a value of $8.12 billion in 2015 and is projected to reach a value $12.53 billion at the end of 2022.

The Global Alopecia Market report covers the Alopecia Market in a comprehensive manner, across all parameters such as types, applications, users, top players, and regions.

The report further covers the drivers, restraints and trends in the Alopecia Market for the customer to understand the intricacies of the Alopecia Market which will help them create an efficient plan of action to grow at the fastest rate across the globe.

The Global Alopecia Market is expected to keep rising at a CAGR of 17.6% for the forecast period of 2017 – 2022. The Global Alopecia Market report provides the customer an accurate analysis of the Alopecia Market to assist them in planning their market entry or expansion.

The forecast projection is compiled by a team of subject matter experts and market research professionals to ensure that the information is accurate and presented in an easy to consume tables, charts, and graphs.

For the customer to be able to plan for a significant period, the Global Alopecia Market report covers projections up to 2022.

The current market scenarios and laws under which the market operates in make it easier to understand how the market will play out for the forecast period. The current trends in the market and the drivers and restrains affecting the market might change with the times.

The top players covered in the report include the following:

Lifes2good, Kirkland Signature, Johnson & Johnson., Dr. Reddy’s Laboratories., Cipla., Alpecin., Vitabiotics., Sun Pharma., Phyto Ales Groupe., Phyto Ales Group, and Merck & Co.

Request a Free Sample of The Report: http://www.orbisresearch.com/contacts/request-sample/184998

The report covers a detailed analysis of each majorly impacting player in the Alopecia Market such as the company profile, the latest developments by the player in the Alopecia Market, and the product portfolio of the player currently available in the Alopecia Market, as well as the regions they operate in majorly.

Alopecia Types Covered:
Alopecia Universalis
Alopecia Totalis
Alopecia Areata

Products Covered:
Shampoos and Conditioners
Vitamins and Supplements
Other Products
Gels and Oils
Serums

Treatment Types Covered:
Hair Transplant Services
Low Level Laser Therapy
Oral Treatment
Topical Treatment
Injectable
Plasma Therapy
Steroids
Injectable Fillers
Other Treatment Types

Genders Covered:
Male
Female

End Users Covered:
Homecare Settings
Aesthetic Clinics
Dermatology And Trichology Clinics
Hospitals
Other End Users

The regions covered in the Global Alopecia Market report include North America (US, Canada, Mexico), Europe (Germany, UK, Italy, France, Spain, Rest of Europe), Asia Pacific (Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific), South America (Argentina, Brazil, Chile, Rest of South America), and Middle East & Africa (Saudi Arabia, UAE, Qatar, South Africa, Rest of Middle East & Africa).

The Global Alopecia Market report covers the SWOT analysis of the Alopecia Market along with key developments in the market that will be helpful for the customer. Anyone with either academic of business interest in the Alopecia Market, the report will definitely by handy.

About

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Source